Capece, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 166
EU - Europa 152
AS - Asia 16
AF - Africa 1
Totale 335
Nazione #
US - Stati Uniti d'America 164
IT - Italia 64
SE - Svezia 23
IE - Irlanda 18
GB - Regno Unito 16
DE - Germania 11
BE - Belgio 8
CN - Cina 8
FI - Finlandia 4
FR - Francia 3
IN - India 2
JP - Giappone 2
NL - Olanda 2
TR - Turchia 2
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
HR - Croazia 1
IR - Iran 1
PH - Filippine 1
PR - Porto Rico 1
UA - Ucraina 1
Totale 335
Città #
Chandler 38
Rome 23
Ashburn 22
Dublin 18
Milan 11
Brussels 8
Boydton 7
New York 7
Fairfield 6
London 6
San Mateo 6
Wilmington 5
Cattolica 4
Beijing 3
Boston 3
Bremen 3
Chicago 3
Falls Church 3
Genova 3
Helsinki 3
Hounslow 3
Mülheim 3
Norwalk 3
Princeton 3
Washington 3
Ann Arbor 2
Bologna 2
Chieti 2
Genoa 2
Hangzhou 2
Houston 2
Istanbul 2
Naples 2
Pune 2
San Diego 2
Tokyo 2
Woodbridge 2
Abidjan 1
Amsterdam 1
Andover 1
Augusta 1
Caloocan City 1
Cambridge 1
Catania 1
Chioggia 1
Chiswick 1
Dordrecht 1
Fuzhou 1
Guangzhou 1
Islington 1
Kherson 1
Kish 1
Lappeenranta 1
Livorno 1
Marseille 1
Montreal 1
Nuremberg 1
Paris 1
Prescot 1
Redwood City 1
Saint Louis 1
San Juan 1
Southwark 1
Stockholm 1
Wandsworth 1
Zagreb 1
Zurich 1
Totale 251
Nome #
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 93
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 77
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences 63
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 35
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 32
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features 30
First-phase insulin secretion: can its evaluation direct therapeutic approaches? 10
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function 5
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 3
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production 3
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study 1
Totale 352
Categoria #
all - tutte 2.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 8 0
2021/202287 2 0 21 8 3 2 8 10 2 5 16 10
2022/2023140 11 11 19 15 3 10 2 7 15 10 18 19
2023/2024117 4 32 10 15 14 13 9 18 2 0 0 0
Totale 352